Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
TAC T-cells for Gastric Cancer
Recruiting1 awardPhase 1 & 2
Chicago, Illinois
This trial is testing a new cell therapy that consists of genetically engineered autologous T cells expressing T-cell Antigen Coupler (TAC) that recognizes human epidermal growth factor receptor 2 (HER2). The purpose of the trial is to establish the safety, maximum tolerated dose, and efficacy of the therapy in subjects with relapsed or refractory solid tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service